Summary
The product TB-500 (TB-4) underwent independent testing for concentration and purity. Submitted by acepharmaadmin@protonmail.com, the sample analysis was conducted by Janoshik Analytical. The measured concentration was 4.59 mg with a purity of 99.961%.
Testing was initiated on 5 July 2024, with the sample received on 18 July 2024. The analysis was completed on the same day, 18 July 2024.
Detailed Report
Product Overview
- Manufacturer: Unknown
- Product Name: TB-500 (TB-4)
- Active Ingredient: TB-500
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #45524
- Testing Ordered: 5 July 2024
- Sample Received: 18 July 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: ACE Pharmaceuticals (Manufacturer)
- Analysis Paid For By: ACE Pharmaceuticals (Manufacturer)
Testing Results
- Label Specification: Not provided
- Measured Concentration: 4.59 mg
- Purity: 99.961%
Verification Details
- Verification URL: https://janoshik.com/tests/45524_I6CHGZA3P4YW
Evaluation of Manufacturer-Submitted Testing
The product demonstrates excellent purity at 99.961%, indicating minimal impurities or contaminants. The measured concentration of 4.59 mg provides a reasonable dosage specification, though no label claim was provided for verification.
Conclusion
The product exhibits high purity with consistent dosage, aligning with expectations for a high-quality peptide.
Disclaimer
This report is for educational purposes and highlights findings based on manufacturer-submitted testing. Independent third-party testing is advised for comprehensive validation.
